Key details
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
Shanghai IASO Biotechnology Co., Ltd
Enrollment target
~24 participants
Primary completion
January 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated December 2021